Status:
RECRUITING
Ultra-Low Field (ULF) Point-of-Care (POC) MRI System for Brain Morphology and Pathology
Lead Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Nervous System Diseases (C10 Unique ID D009422)
Eligibility:
All Genders
3-99 years
Brief Summary
Background: Magnetic resonance imaging (MRI) is a tool for getting pictures of the tissues and organs inside the body. MRI can help diagnose many injuries and diseases. But not all patients are equal...
Detailed Description
Study Description: Within the long-term goal of establishing a mobile research unit, this protocol aims at better understanding the utility and applicability of ULF MRI to deliver accessible neuroima...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Volunteer of any gender, 3 years of age and older.
- Adult participant: must be capable of understanding the procedures and requirements of this study and be able and willing to sign an informed consent document.
- Minor participant: Must have a parent or guardian capable of understanding the procedures and requirements of this study who are willing to sign an informed parental consent document, and where feasible, the minor age 7 and older provides assent.
- Either:
- Adult in good general health as evidenced by medical history or
- Diagnosed with a stroke, a neurological or neuro-oncological disease, or
- Exhibiting symptoms suggestive of neurological or neuro-oncological disease.
- EXCLUSION CRITERIA:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Unable to undergo MRI study based on screening (e.g., presence of non-MRI compatible objects).
- Pregnancy or lactation, if contrast agent is required.
Exclusion
Key Trial Info
Start Date :
March 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06203626
Start Date
March 26 2024
End Date
December 31 2027
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892